Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review

Dyslipidaemia is one of the main causes of atherosclerotic cardiovascular disease (ASCVD) worldwide. Although statins remain the cornerstone of lipid-lowering therapy, many patients do not achieve optimal target levels of low-density lipoprotein cholesterol (LDL-C) due to intolerance or inadequate r...

Full description

Bibliographic Details
Published in:Biomedicines
Main Authors: Dominik Strikic, Zvonimir Begic, Ivana Radman, Fran Zlopasa, Jana Mateljic, Ivica Zec, Marina Titlic, Ana Marija Sliskovic, Ivan Pecin, Zeljko Reiner, Iveta Mercep
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Subjects:
dyslipidaemia
bempedoic acid
statin intolerance
cardiovascular risk
lipid-lowering therapy
Online Access:https://www.mdpi.com/2227-9059/13/6/1460

Internet

https://www.mdpi.com/2227-9059/13/6/1460

Similar Items